Therapy Strategies After LAA Occluder Device Embolization
LAAODE
Device Embolization After Percutaneous Left Atrial Appendage Occlusion: Risk Factors, Approaches and Outcomes
1 other identifier
observational
400
1 country
1
Brief Summary
The investigators thought to evaluate risk factors, therapeutic approaches and outcomes after left atrial appendage occluder device embolization (LAAO, either surgical or interventional).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2020
CompletedFirst Submitted
Initial submission to the registry
August 12, 2021
CompletedFirst Posted
Study publicly available on registry
August 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJuly 26, 2022
July 1, 2022
1 year
August 12, 2021
July 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Procedural mortality
all-cause mortality during the index procedure, any procedure-related death within 30days or during in-hospital stay for the index procedure (if\>30days)
In-hospital stay, assessed up to 30 days
Need for cardiac surgery
In-hospital stay, assessed up to 30 days
Catheter-based retrieval of LAA Occluder
peri-procedural device removal
up to 5 years (after device implantation)
Secondary Outcomes (2)
Further complications
up to 5 years (after device implantation)
Risk factors
up to 30 days (after device implantation)
Study Arms (1)
Patients experiencing device embolization after left atrial appendage occlusion
Device embolization following either surgical or interventional left atrial appendage occlusion
Interventions
After LAA device embolization there are different approaches to dealing with the occluder dislocation. The aim is to find out which way leads to the best outcomes.
Eligibility Criteria
Patients after interventional or surgical left atrial appendage occlusion with device embolization
You may qualify if:
- Patients after interventional or surgical left atrial appendage occlusion with device embolization
You may not qualify if:
- n/a
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cardiovascular Center Frankfurtlead
- Kerstin Piayda, CardioVascular Center Frankfurt, Frankfurt, Germanycollaborator
- Kolja Sievert, CardioVascular Center Frankfurt, Frankfurt, Germanycollaborator
- Roberto Galea, Universitätsspital Bern, Bern, Switzerlandcollaborator
- Moniek Maarse, St. Antonius Ziekenhuis, Nieuwegein, Netherlandscollaborator
- Sheba Medical Centercollaborator
- Andrey Osadchiy, City Hospital #40, St. Petersburg, Russiacollaborator
- Andrey Kalemberg, National Research Center, Moscow, Russiacollaborator
- Jung-Sun Kim, Yonsei University Hospital, Seoul, South Koreacollaborator
- Aarhus University Hospitalcollaborator
- Sajjad A Sabir, Cooper University Hospital, NJ, USAcollaborator
- Ashish Pershad, Banner Health, Phoenix, Arizona, USAcollaborator
- Markus Sandri, Herzzentrum Leipzig, Leipzig, Germanycollaborator
- Jens-Erik Nielsen-Kudsk, University Hospital Aarhus, Aarhus, Denmarkcollaborator
- George Mark, The Heart House/Cooper University Camden, NJ, USAcollaborator
- Dhiraj Gupta, Liverpool Heart and Chest Hospital, Liverpool, UKcollaborator
- Pradhum Ram, Emory University, USAcollaborator
- Rigshospitalet, Denmarkcollaborator
- Norbert Klein, Klinikum St. Georg, Leipzig, Germanycollaborator
- Josep Rodes, Laval Hospital, Quebec, Canadacollaborator
- Shazia Afzal, Heinrich-Heine University, University Hospital, Duesseldorfcollaborator
- Xavier Millán Alvarez, Hospital de la Santa Creu i Sant Pau, Barcelona, Spaincollaborator
- James E. Harvey, WellSpan Health, York, PA, USAcollaborator
- Wern Yew Ding, University of Liverpool, Liverpool, UKcollaborator
- Adel Aminian, Centre hospitalier universitaire de Charleroi, Brussels, Belgiumcollaborator
- Pamela Moceri, Hopital Pasteur 1, Nice, Francecollaborator
- Ibrahim Akin, Universitätsmedizin Mannheim, Germanycollaborator
- Jacques Mansourati, Hôpital de la Cavale Blanche, Brest, Francecollaborator
- Eloi Marijon, Hôpital Européen Georges-Pompidou HEGP, Paris, Francecollaborator
- Ignacio Amat Santos, University Clinical Hospital of Valladolid, Valladolid, Spaincollaborator
- Hana Vaknin Assa, Beilinson Hospital, Israelcollaborator
- Thomas Robert Schmidt, Herzzentrum Dresden GmbH Universitätsklinik, Dresden, Germanycollaborator
- Ran Kornowski, Rabin Medical Center, Petah Tiqwa, Israelcollaborator
- Giacomo Boccuzzi, Ospedale san Giovanni Bosco, Torino, Italycollaborator
- Christopher R. Ellis, Vanderbilt University, Nashville, TN, USAcollaborator
- Henning Ebelt, Katholisches Krankenhaus St. Nepomuk, Erfurt, Germanycollaborator
- Guy's and St Thomas' NHS Foundation Trustcollaborator
- Sonja Lehmann, Hôpital Fribourgeois, Freiburg, Swizerlandcollaborator
- Oh-Hyun Lee, Yonsai University Hospital, Yongin, Koreacollaborator
- Wendy Schell, Cooper University Hospital, NJ, USAcollaborator
- Domenico della Rocca, St David's Medical Center, Austin, Texas, USAcollaborator
- Pablo Pinon Esteban, Hospital Universitario A Coruña, Spaincollaborator
- Jose Gabriel Galache Osuna, Miguel Servet University Hospital, Zaragoza, Spaincollaborator
- Enio Guerios, Hospital Pilar, Curitiba, Brazilcollaborator
- Nicolas Amabile, Institut Mutualiste Montsouris, Paris, Francecollaborator
- Ignacio Cruz Gonzalez, University Hospital of Salamanca, Castillay Leon, Spaincollaborator
- Weita Chen, Taipei Municipal Wanfang Hospital, Taipei, Taiwancollaborator
- Sandeep Kumar Goyal, Piedmont Heart Institute Buckhead, Atlanta, GA, USAcollaborator
- Francesco Gianni, Maria Cecilia Hospital, Cotignola, Italycollaborator
- Máximo Rivero Ayerza, Ziekenhuis Oost Limburg, Genk, Belgiumcollaborator
- Carsten Skurk, Charité, Universitätsmedizin Berlin, Berlin, Germanycollaborator
- Martin Langel, Klinikum St. Georg, Leipzig, Germanycollaborator
- Livia Gheorghe, Hospital de la Santa Creu I Santa Pau, Barcelona, Spaincollaborator
- Lino Santos, Centro Hospitalar Vila Nova de Gaia, Vila Nova de Gaia, Portugalcollaborator
- Royal Victoria Hospital, Belfastcollaborator
- Luis Nombela-Franco, Hospital Clínico San Carlos, Madrid, Spaincollaborator
- Francesco Nappi, Centre Cardiologique du Nord de Saint-Denis, Paris, Francecollaborator
- Matteo Montorfano, Ospedale San Raffaele, Segrate, Milan, Italycollaborator
- Juan Fernández-Armenta, Hospital Universitario Puerta del Mar, Cádiz, Spaincollaborator
- Michael Kühne, Universitätsspital Basel, Basel, Swizerlandcollaborator
- Jesper van der Pals, Lund University Hospital, Lund, Sweden.collaborator
- Can Yücel Karabay, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Center, Istanbul, Turkeycollaborator
- Marco Ancona, San Raffaele Scientific Institute, Milan, Italycollaborator
- Ghassan Moubarak, Clinique Ambroise Paré, Neuilly-sur-Seine, Francecollaborator
- Tom De Potter, OLV Hospital, Aalst, Belgiumcollaborator
- Mathieu Lempereur, CHU de Liège, Belgiumcollaborator
- Clinton Health Access Initiative Inc.collaborator
- Evgeny Merkulov, Scientific Research Center, Moscow, Russiacollaborator
- Liesbeth Rosseel, ASZ Aalst, Belgiumcollaborator
- Antti Saraste, Heart Center, Turku University Hospital, Turku, Finlandcollaborator
- Ahmet Güner, Mehmet Akif Ersoy Hospital, Turkeycollaborator
- Achille Gaspardone, San Eugenio Hospital ASL Roma, Italycollaborator
Study Sites (1)
CardioVascular Center (CVC) Frankfurt
Frankfurt on the Main, Hesse, 60389, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Sophie Eppinger
CardioVascular Center (CVC) Frankfurt, Seckbacher Landstraße 65, 60389 Frankfurt am Main, Hesse, Germany
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
August 12, 2021
First Posted
August 20, 2021
Study Start
September 30, 2020
Primary Completion
September 30, 2021
Study Completion
December 31, 2023
Last Updated
July 26, 2022
Record last verified: 2022-07